340
Participants
Start Date
November 30, 2021
Primary Completion Date
April 30, 2023
Study Completion Date
April 30, 2023
BNT162b2
BNT162b2 is an mRNA vaccine to prevent COVID-19 infection and is approved by the emergency use of authorization (EUA) by the Taiwan FDA.
mRNA-1273
mRNA-1273 is an mRNA vaccine to prevent COVID-19 infection and is approved by the emergency use of authorization (EUA) by the Taiwan FDA.
MVC-COV1901
MCV COVID-19 vaccine is a protein subunit vaccine containing S2P S-protein which passes the EUA by Taiwan FDA.
Chang Gung Memorial Hospital, Taoyuan
Collaborators (1)
Medigen Vaccine Biologics Corp.
INDUSTRY
Chang Gung Memorial Hospital
OTHER